Longeveron Inc. [NASDAQ: LGVN] closed the trading session at $6.39 on 05/21/21. The day’s price range saw the stock hit a low of $5.77, while the highest price level was $7.52. The company report on May 18, 2021 that Longeveron Announces the Hiring of Dan Gincel, Ph.D., as Senior Vice President, Strategic Collaborations & Scientific Affairs.
Will Lead Business Development Activities After 14 Years as Executive Director of Maryland Stem Cell Research Fund.
Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, announced the hiring of Dan Gincel, Ph.D. as Senior Vice President, Strategic Collaborations & Scientific Affairs.
The stocks have a year to date performance of -13.77 percent and weekly performance of 20.57 percent. The stock has performed 11.52 percent around the most recent 30 days and changed -6.03 percent over the most recent 3-months.
If compared to the average trading volume of 820.89K shares, LGVN reached to a volume of 2265460 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Longeveron Inc. [LGVN]:
The Average True Range (ATR) for Longeveron Inc. is set at 0.45, with the Price to Sales ratio for LGVN stock in the period of the last 12 months amounting to 19.59. The Price to Book ratio for the last quarter was 4.23, with the Price to Cash per share for the same quarter was set at 1.43.
LGVN stock trade performance evaluation
Longeveron Inc. [LGVN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 20.57.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for LGVN stock in for the last two-week period is set at 57.57, with the RSI for the last a single of trading hit 64.54, and the three-weeks RSI is set at 53.24 for Longeveron Inc. [LGVN]. The present Moving Average for the last 50 days of trading for this stock 6.33, while it was recorded at 5.85 for the last single week of trading.
Longeveron Inc. [LGVN]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Longeveron Inc. [LGVN] shares currently have an operating margin of -67.12 and a Gross Margin at +18.49. Longeveron Inc.’s Net Margin is presently recorded at -66.09.
Return on Total Capital for LGVN is now -51.47, given the latest momentum, and Return on Invested Capital for the company is -55.09. Return on Equity for this stock declined to -116.24, with Return on Assets sitting at -37.54. When it comes to the capital structure of this company, Longeveron Inc. [LGVN] has a Total Debt to Total Equity ratio set at 211.61. Additionally, LGVN Total Debt to Total Capital is recorded at 67.91, with Total Debt to Total Assets ending up at 44.82. Long-Term Debt to Equity for the company is recorded at 176.46, with the Long-Term Debt to Total Capital now at 56.63.
Reflecting on the efficiency of the workforce at the company, Longeveron Inc. [LGVN] managed to generate an average of -$310,067 per employee. Receivables Turnover for the company is 12.91 with a Total Asset Turnover recorded at a value of 0.57.Longeveron Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 9.10 and a Current Ratio set at 9.10.
Longeveron Inc. [LGVN]: Insider Ownership positions
10 institutional holders increased their position in Longeveron Inc. [NASDAQ:LGVN] by around 85,162 shares. Additionally, 0 investors decreased positions by around 0 shares, while 0 investors held positions by with 0 shares. The mentioned changes placed institutional holdings at 85,162 shares, according to the latest SEC report filing. LGVN stock had 10 new institutional investments in for a total of 85,162 shares, while 0 institutional investors sold positions of 0 shares during the same period.